Seeing Is Believing

Currently out of the existing stock ratings of Greg Harrison, 87 are a BUY (71.9%), 29 are a HOLD (23.97%), 5 are a SELL (4.13%).
Analyst Greg Harrison, currently employed at BAML, carries an average stock price target met ratio of 59.38% that have a potential upside of 36.85% achieved within 157 days.
Greg Harrison’s has documented 235 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VRTX, Vertex Pharmaceuticals at 13-Nov-2025.
Analyst best performing recommendations are on OMER (OMEROS).
The best stock recommendation documented was for OMER (OMEROS) at 11/8/2022. The price target of $3 was fulfilled within 1 day with a profit of $0.2 (6.25%) receiving and performance score of 62.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$6.25
$6.24 (62400.00%)
$25
3 years 5 months 27 days ago
(23-May-2022)
1/3 (33.33%)
$0.9 (16.82%)
14
Buy
$11
4 years 9 months 2 days ago
(17-Feb-2021)
1/1 (100%)
$-23.25 (-67.88%)
998
Buy
$125
$124.57 (28969.77%)
5 years 6 months 11 days ago
(08-May-2020)
0/1 (0%)
$54 (76.06%)
Which stock is Greg Harrison is most bullish on?
Which stock is Greg Harrison is most reserved on?
What Year was the first public recommendation made by Greg Harrison?